INKT
MiNK Therapeutics, Inc. - Common Stock (INKT)
$26
About MiNK Therapeutics, Inc. - Common Stock (INKT)
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
Details
Daily high
$7.34
Daily low
$7.11
Price at open
$7.11
52 Week High
$13.79
52 Week Low
$4.56
Market cap
28.9M
Dividend yield
0.00%
Volume
3,280
Avg. volume
2,738
P/E ratio
-2.90
MiNK Therapeutics, Inc. - Common Stock News
Details
Daily high
$7.34
Daily low
$7.11
Price at open
$7.11
52 Week High
$13.79
52 Week Low
$4.56
Market cap
28.9M
Dividend yield
0.00%
Volume
3,280
Avg. volume
2,738
P/E ratio
-2.90